Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for Severe COVID-19
NCT04244591Phase 3Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2020
- Primary completion
- Apr 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone in coronavirus disease 2019 (COVID-19), sponsored by Peking Union Medical College Hospital. Started Jan 2020; status: completed.
02
Drugs
methylprednisolone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04244591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04244591.